We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 5,518 results
  1. Antagonists of the Mu-Opioid Receptor in the Cancer Patient: Fact or Fiction?

    Purpose of Review

    Antagonists of mu-opioid receptor role in cancer progression remains to be elucidated. The objective of this review was to summarize...

    Amparo Belltall, Guido Mazzinari, ... María Pilar Argente Navarro in Current Oncology Reports
    Article Open access 01 June 2022
  2. Opioid antagonism in humans: a primer on optimal dose and timing for central mu-opioid receptor blockade

    Non-human animal studies outline precise mechanisms of central mu-opioid regulation of pain, stress, affiliation and reward processing. In humans,...

    Martin Trøstheim, Marie Eikemo, ... Siri Leknes in Neuropsychopharmacology
    Article Open access 17 August 2022
  3. Metabolic Profiles Associated with Opioid Use and Opioid Use Disorder: a Narrative Review of the Literature

    Purpose of Review

    Opioid use disorder (OUD) is a chronic, relapsing condition that is epidemic in the USA. OUD is associated with serious adverse...

    Juliana I. Byanyima, **nyi Li, ... Corinde E. Wiers in Current Addiction Reports
    Article 19 May 2023
  4. Therapeutic Innovations Against Opioid Tolerance and Addiction

    Purpose of Review

    Opioids have a long history of use for relief of pain dating back thousands of years. Opium derived from the poppy plant is one of...

    M. Berk Basaran, Raviye Ozen Koca, Z. Isik Solak Gormus in Current Behavioral Neuroscience Reports
    Article 02 May 2024
  5. Selective Opioid Antagonists Following Bowel Resection for Prevention of Postoperative Ileus: a Systematic Review and Meta-analysis

    Background

    Postoperative ileus (POI) remains a common complication following bowel resection. Selective opioid antagonists have been increasingly...

    Tyler McKechnie, Tharani Anpalagan, ... Cagla Eskicioglu in Journal of Gastrointestinal Surgery
    Article 25 March 2021
  6. µ-Opioid receptor antagonism facilitates the anxiolytic-like effect of oxytocin in mice

    Mood and anxiety disorders are leading causes of disability worldwide and are major contributors to the global burden of diseases. Neuropeptides,...

    Khalin E. Nisbett, Leandro F. Vendruscolo, George F. Koob in Translational Psychiatry
    Article Open access 28 February 2024
  7. Cancer Pain Management in Patients with Opioid Use Disorder

    Purpose of review

    Updated cancer pain management recommendations considering the rise of opioid use disorder (OUD) and opioid overdose deaths. Few...

    Katrina Nickels, Justin Kullgren, ... J. Janet Ho in Current Addiction Reports
    Article 03 May 2024
  8. Neuropsychiatric Effects Associated with Opioid-Based Management for Palliative Care Patients

    Purpose of Review

    The abundance of opioids administered in the palliative care setting that was once considered a standard of care is at present...

    Alan D. Kaye, Kylie Dufrene, ... Christopher L. Robinson in Current Pain and Headache Reports
    Article 02 April 2024
  9. Total-body imaging of mu-opioid receptors with [11C]carfentanil in non-human primates

    Purpose

    Mu-opioid receptors (MORs) are widely expressed in the central nervous system (CNS), peripheral organs, and immune system. This study measured...

    Chia-Ju Hsieh, Catherine Hou, ... Robert H. Mach in European Journal of Nuclear Medicine and Molecular Imaging
    Article Open access 09 May 2024
  10. A Nationwide Hospital Claims Database Analysis of Real-World Patterns of Laxative Use for Opioid-Induced Constipation in Japanese Patients with Cancer

    Introduction

    Opioid-induced constipation (OIC) is one of the most common side effects in patients with cancer treated with opioid analgesics. The...

    Takahiro Higashibata, Takaomi Kessoku, ... Takayuki Hisanaga in Pain and Therapy
    Article Open access 17 May 2023
  11. AM6527, a neutral CB1 receptor antagonist, suppresses opioid taking and seeking, as well as cocaine seeking in rodents without aversive effects

    Preclinical research has demonstrated the efficacy of CB1 receptor (CB1R) antagonists in reducing drug-taking behavior. However, clinical trials with...

    Omar Soler-Cedeño, Hannah Alton, ... Zheng-**ong ** in Neuropsychopharmacology
    Article Open access 10 April 2024
  12. Pharmacological treatment of cancer pain and opioid induced nausea and vomiting: online survey and comparison with current guidelines

    Purpose

    We assumed that in Palliative Care, even in common clinical situations, the choice of drugs differs substantially between physicians....

    Jan Gaertner, Christopher Boehlke, ... Carmen Roch in Supportive Care in Cancer
    Article Open access 15 June 2024
  13. Subthreshold opioid use disorder prevention (STOP) trial: a cluster randomized clinical trial: study design and methods

    Background

    Preventing progression to moderate or severe opioid use disorder (OUD) among people who exhibit risky opioid use behavior that does not...

    Jane M. Liebschutz, Geetha A. Subramaniam, ... Jennifer McNeely in Addiction Science & Clinical Practice
    Article Open access 18 November 2023
  14. The endogenous opioid system in the medial prefrontal cortex mediates ketamine’s antidepressant-like actions

    Recent studies have implicated the endogenous opioid system in the antidepressant actions of ketamine, but the underlying mechanisms remain unclear....

    Cheng Jiang, Ralph J. DiLeone, ... Ronald S. Duman in Translational Psychiatry
    Article Open access 12 February 2024
  15. Understanding the Causal Relationships Between Opioid Dependence and Risk of Mental Disorders: A Comprehensive Two-Sample Mendelian Randomization Study

    Observational studies have reported positive associations between opioid dependence and major mental disorders. However, the causal relationships and...

    Yundi Hu, Luheng Qian, ... **aolei Lin in International Journal of Mental Health and Addiction
    Article 30 April 2024
  16. Aticaprant, a kappa opioid receptor antagonist, and the recovered ‘interest and pleasure’ in the concept of major depressive disorder

    Lack of positive mood and anhedonia probably are the most specific depressive symptoms. Anhedonia is a multifaceted concept: the clinical language...

    Article 06 July 2024
  17. Effect of TRV130 and methadone on fentanyl-vs.-food choice and somatic withdrawal signs in opioid-dependent and post-opioid-dependent rats

    The high efficacy mu-opioid receptor (MOR) agonist methadone is an effective opioid use disorder (OUD) medication used exclusively in...

    E. Andrew Townsend, Bruce E. Blough, ... Matthew L. Banks in Neuropsychopharmacology
    Article 29 July 2022
  18. The Role of Medicinal Cannabis as an Emerging Therapy for Opioid Use Disorder

    This narrative review explores current insights into the potential use of medicinal cannabis-related products as an emerging therapy for opioid use...

    Kelvin Le, Khang Duy Ricky Le, ... Sarah Munday in Pain and Therapy
    Article Open access 27 April 2024
  19. Possible unusual presentation of opioid side effect in a child: a case report

    Atypical presentations are commonly encountered in the Pediatric intensive care unit (PICU) but having a high index of suspicion is crucial to...

    Moukhaiber Jihane, Lakissian Zavi, Majdalani Marianne in BMC Pediatrics
    Article Open access 15 January 2024
  20. Robotic living donor nephrectomy is associated with reduced post-operative opioid use compared to hand-assisted laparoscopic approach

    Background

    Robotic donor nephrectomy (RDN) has emerged as a safe alternative to laparoscopic donor nephrectomy (LDN). Having previously demonstrated...

    Amen Z. Kiani, Kristin Progar, ... Adeel S. Khan in Surgical Endoscopy
    Article 22 May 2024
Did you find what you were looking for? Share feedback.